AMYTRX THERAPEUTICS
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies for patients with chronic inflammatory diseases. The company's AMTX-100 is bioengineered using human protein sequences that modulate the immune system by a natural process. Amytrx Therapeutics was founded in 2014 by Matthew A. Gonda and is based in Nashville, Tennessee.
AMYTRX THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2014-01-01
Address:
Nashville, Tennessee, United States
Country:
United States
Website Url:
http://www.amytrx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
29 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Content Delivery Network COVID-19 Wix Wix Media
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Swiftscale Biologics
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics.
Current Employees Featured
Founder
Official Site Inspections
http://www.amytrx.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Amytrx Therapeutics"
About - Amytrx Therapeutics
Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for patients suffering from chronic inflammatory diseases. We …See details»
Amytrx Therapeutics - Crunchbase Company Profile & Funding
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies for patients with chronic inflammatory diseases. The …See details»
Amytrx Therapeutics, Inc. - LinkedIn
Amytrx Therapeutics, Inc. Biotechnology Research Nashville, TN 1,009 followers Advancing a new class of anti-inflammatory peptides to deliver breakthrough disease-altering therapies.See details»
Amytrx Therapeutics Company Profile 2024: Valuation, Funding ...
Nov 19, 2017 Amytrx Therapeutics General Information Description. Developer of anti-inflammatory peptide medicines intended to treat inflammation and metabolic disorders. …See details»
Amytrx Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Amytrx Therapeutics Inc of Nashville, TN. Get the latest business insights from Dun & Bradstreet.See details»
Amytrx Therapeutics - Org chart - The Org
Explore Amytrx Therapeutics' organizational chart. Discover current team members including executives, board members, and advisors.See details»
Amytrx Therapeutics Welcomes Two Renowned Scientists to its …
Nov 7, 2023 Amytrx Therapeutics, Inc. is a clinical-stage biopharmaceutical company pioneering the first anti-inflammatory human peptide platform (AMTX-100) yielding the potential for vastly …See details»
Advancing the Next Generation of Inflammation-Targeting …
Amytrx Therapeutics, Inc. www.amytrx.com Contact: Amytrx Contact: Maya Frutiger, VP of Corporate Affairs 214-668-2916 [email protected] Interview conducted by: Lynn Fosse, …See details»
Amytrx Therapeutics - Contacts, Employees, Board Members
Amytrx Therapeutics has 1 current employee profile, President, CEO, Co-Founder, and Director Matthew Gonda. Matthew Gonda President, CEO, Co-Founder, and Director Unlock even …See details»
Collaboration | Amytrx Therapeutics
At Amytrx Therapeutics, our mission is to deliver immune-modulating support with our peptide platforms while minimizing harm to the patient in the process. Beginning with topical solutions …See details»
Amytrx Therapeutics - VentureRadar
Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for patients suffering from chronic inflammatory diseases. Resolution of inflammatory diseases involves an active process of reprogramming cells using mechanisms that limit inflammation to restore immune balance.See details»
Amytrx Therapeutics - Overview, News & Similar companies
May 25, 2022 Who is Amytrx Therapeutics. Amytrx is a clinical-stage biopharmaceutical company advancing the next generation of new anti-inflammatory peptide therapies for …See details»
Amytrx Therapeutics Comes Out of the Gate Strong
Sep 17, 2020 Amytrx has achieved several important milestones in early 2020, advancing a potentially best-in-class topical formulation of AMTX-100 into clinical development for …See details»
Amytrx Therapeutics Partners With AmbioPharm to Expand the …
Jul 26, 2022 Amytrx is a clinical-stage biopharmaceutical company pioneering the first anti-inflammatory human peptide platform (AMTX-100) yielding the potential for vastly optimized, …See details»
Amytrx Therapeutics, Inc. - Research - Overview ... - Apollo.io
Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients.Drawing on 25 years of research, Amytrx is harnessing the power of novel anti-inflammatory peptide discoveries to advance new medicines aimed at the prevention and treatment of inflammatory diseases.See details»
Amytrx Enrolling Clinical Trial of AMTX-100 in Patients with Atopic ...
Oct 12, 2020 Amytrx's product is a first-in-class cell-penetrating peptide bioengineered entirely from human protein sequences. The mechanism of action of AMTX-100 is well understood. ...See details»
AMTX-100 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 About Amytrx Therapeutics Amytrx Therapeutics, Inc. is a clinical-stage biopharmaceutical company pioneering the first anti-inflammatory human peptide platform …See details»
News | Amytrx Therapeutics
July 25th, 2023 - Amytrx Therapeutics' AMTX-100 Phase 1 Clinical Trial Data Presented at Revolutionizing Atopic Dermatitis Conference ….. read more November 7th, 2022 - A recent …See details»
Amytrx Therapeutics raises $18M for new therapeutic …
May 25, 2022 About Amytrx Therapeutics Amytrx is a clinical-stage biopharmaceutical company pioneering the first anti-inflammatory human peptide platform (AMTX-100) yielding the …See details»